This is a list of major organizations involved in NTDs countermeasures in Japan and the projects implemented in 2019-2020.
(Note: This list is not intended to cover all related organizations and will be updated from time to time. If you would like to add or remove from the list, please contact the secretariat.)
- The Ministry of Health, Labor and Welfare and the Ministry of Economy, Trade and Industry have also budgeted for AMED, but it is not used for NTDs-related projects.
- The Gates Foundation and Wellcome Trust have also contributed to the GHIT Fund.
- There are many other pharmaceutical companies that are funding the GHIT Fund and companies that are subsidized by GHIT, but due to space limitations, only Full Partners are shown here.
- It does not list the NTD Parliamentary League or the organizations involved in NTDs advocacy in the country.
- The National Institute of Infectious Diseases is conducting research on some NTDs (leprosy, dengue fever) with funding from the Ministry of Health, Labor and Welfare, but it was omitted because it was considered that domestic measures were the main purpose.
- The Ministry of Health, Labor and Welfare has budgeted for the leprosy control project, but it was considered as a domestic project and omitted.
International Health Policy Office, International Cooperation Bureau, Ministry of Foreign Affairs
- Foreign policy on international healthIn charge of
- Responsible for activities through international organizations, policy dialogues and exchange projects with other countries, and information dissemination in fields that Japan is proud of in the world. Mainly compatible with WHO.
- WHO Africa Secretariat NTDs Countermeasure ProgramESPENContributed to.
Independent administrative agency
Japan International Cooperation Agency (JICA)
- Technical cooperation project
- Oceania Wide Area Philaria Countermeasures Project, Micronesia, Tuvalu, Fiji, Papua New Guinea, Samoa, Kiribati, October 2018-February 2022
- Grassroots technical cooperation
- Examination of a resident-centered Thai liver fluke prevention measure model realized through collaboration between local residents and local health administration, Cambodia, February 2018-January 2021
Japan Agency for Medical Research and Development (AMED)
- International Collaborative Research Program for Neglected Tropical Diseases (NTDs) Control in Africa
- Development of Rapid Diagnostic Method and Creation of Neglected Tropical Disease Control Model Based on Risk Analysis, Zambia, End of 2019
- Multidisciplinary study for dengue vector mosquito control in Burkina Faso, West Africa, Burkina Faso, end of 2019
- Building an Innovative Network for a Continental Surveillance Network that Contributes to Africa's NTD Countermeasures: Deployment Based on Bulk and Simultaneous Diagnosis Technology, Kenya, End of 2019
- Integrated intervention for Buruli ulcer and other skin NTDs in West Africa, Côte d'Ivoire Ghana, launched 2018
- International Science and Technology Cooperation Program for Global Issues (SATREPS) --Joint project with JICA
- Project to identify viral infections and establish laboratory diagnostics, which is a public health problem, Gabon, April 2016-April 2021
- Ecological research on flying foxes and involvement in rabies-related and other viral infections, Indonesia, July 2015-July 2020
- One Health Approach Preventive and Treatment Network Model Building Project for Rabies Elimination in the Philippines, Philippines, August 2018-2023
- Innovative technological development research by genetic epidemiology for controlling the spread of malaria and important parasites, Laos, May 2014-April 2019
- Integrated R & D to control Chagas disease, El Salvador, April 2018-March 2023
A public-private fund that invests in the development of therapeutics, vaccines and diagnostics for malaria, tuberculosis and neglected tropical diseases. Invested by the Japanese government, pharmaceutical companies, Bill & Melinda Gates Foundation, Wellcome Trust, etc. The projects that are in clinical trials are as follows:
- Astellas Pharma " Development of pediatric product for schistosomiasis " -GHIT Fund grant project
- Eisai " Development of Mycetoma Therapeutics " -GHIT Fund Grant Program
- Takeda Pharmaceutical Company " Development of therapeutic drug for visceral leishmaniasis " -GHIT Fund subsidy project
- Takeda Pharmaceutical Company " Phase 3 clinical trial of dengue vaccine "
In addition, regarding the participation of private companiesPharmaceutical Cooperative HPSee.
Private foundation / non-governmental organization
Sasakawa Health Foundation Hansen's disease countermeasure business
Various studies funded by Kakenhi Grant-in-Aid for Scientific Research DatabasePlease refer to.